α1-Adrenergic receptor coupling with G(h) in the failing human heart

Circulation

Volumn 94, Issue 4, 1996, Pages 718-726

  Hwang, Ki Chul ^b   Gray, Caroline D ^b   Sweet, Wendy E ^a   Moravec, Christine S ^a   Im, Mie Jae ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Cleveland Clinic Foundation ^*

Author keywords

heart failure; proteins; receptors, adrenergic, alpha; signal transduction; transglutaminase II

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; GUANOSINE TRIPHOSPHATE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; FEMALE; HEART DILATATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION;

EID: 0029739664     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.718     Document Type: Article

References (54)

1. 1-adrenoceptor: an overview. Pharmacol Rev. 1993;45:147-175.
2. 1-Adrenoceptor in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol Rev. 1993;73:469-487.
3. 2+. Pharmacol Rev. 1988;40:87-119.
4. Simpson PC, Kariya K, Karns LR, Long CS, Karlinker JS. Adrenergic hormone and control cardiac myocyte growth. Mol Cell Biochem. 1991;104:35-43.
5. van Bilsen M, Chien KR. Growth and hypertrophy of the heart: towards an understanding of cardiac specific and inducible gene expression. Cardiovasc Res, 1993;27:1140-1149.
6. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. α- and β-Adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. J Biol Chem. 1990; 265:13809-13817.
7. Starksen NF, Simpson PC, Bishopric N, Coughlin SR, Lee WM, Escobedo JA, Williams LT. Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A. 1986;83:8348-8350.
8. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem. 1994;269:3775-3782.
9. 1-Adrenergic stimulation of cardiac gene transcription in neonatal rat myocardial cells. J Biol Chem. 1988;263:7352-7357.
10. 1-Adrenergic receptor stimulation of sarcomeric actin isogene transcription in hypertrophy of cultured rat heart muscle cells. J Clin Invest. 1989;83:1078-1082.
11. 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation. 1991;84:1608-1614.
12. Hwa J, De Young MB, Perez DM, Graham MG. Autonomic control of myocardium: alpha-adrenoceptor mechanisms. In: Burnstock E, ed. The Autonomic Nervous System, Vol VIII: The Nervous Control of the Heart. Shepherd J, Vatner SF, volume editors. Cambridge, Mass: Harvard Academic Press; 1996.
13. 1- and β-adrenergic receptor numbers in different species. Am J Physiol. 1983;245:H947-H961.
14. 1-adrenoceptor densities in different mammalian species. Br J Pharmacol. 1992;107:185-188.
15. Corr PB, Shayman JA, Kramer JB, Kipnis RJ. Increased α-adrenergic receptors in ischemic cat myocardium: a potential mediator of electrophysiological derangements. J Clin Invest. 1981;67:1232-1236.
16. 1-adrenoceptor in the ischemic and reperfused myocardium. J Mol Cell Cardiol. 1988;20:725-735.
17. 1-adrenergic receptors in the non-failing and failing human heart. J Pharmacol Exp Ther. 1988;247:1039-1045.
18. 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol. 1992;105:463-469.
19. 1-adrenergic receptor stimulation and blockade on contractility in humans. Circulation. 1991;84:1608-1614.
20. Boehm M, Diet F, Feiler G, Kemkes B, Erdmann E. α-Adrenoceptors and α-adrenoceptor-mediated positive inotropic effects in failing human myocardium. J Cardiovasc Pharmacol. 1988;12:357-364.
21. Jakob H, Nawrath H, Rupp J. Adrenoceptor-mediated changes of action potential and force of contraction in human isolated ventricular heart muscle. Br J Pharmacol. 1988;94:584-590.
22. 1-Adrenergic action: receptor subtypes, signal transduction and regulation. Cell Signal. 1993;5:539-547.
23. 1-adrenoceptors: consensus update. Pharmacol Rev. 1995;47:267-270.
24. 1-adrenergic receptor subtype. J Biol Chem. 1990;265:8183-8189.
25. 1D-adrenergic receptors to multiple signaling pathways is both G protein and cell type specific. Mol Pharmacol. 1993;44:784-795.
26. 1-adrenergic receptor, I: identification by photolabeling of membrane and ternary complex preparations. J Biol Chem. 1990;265:18944-18951.
27. 1-adrenergic receptor, II: purification, characterization and reconstitution. J Biol Chem. 1990;265:18952-18960.
28. 1,-adrenergic signal system. J Biol Chem. 1993;268:27398-27405.
29. h: a GTP-binding protein with transglutaminase activity and receptor signaling function. Science. 1994;264:1593-1595.
30. h (transglutaminase II) with phospholipase C. J Biol Chem. 1995;270:27058-27062.
31. h7 from bovine heart, and immunological characterization. J Biol Chem. 1993;268:27390-27397.
32. 1-adrenoceptors stimulate a high-affinity GTPase activity in sarcolemmal membranes from rabbit atrial and ventricular myocytes. Eur J Biochem. 1993;213:57-65.
33. Folk JE. Transglutaminases. Annu Rev Biochem. 1980;49:517-531.
34. Slife CW, Dorsett MD, Bouquett GT, Register A, Taylor E, Conroy S. Subcellular localization of a membrane-associated transglutaminase activity in rat liver. Arch Biochem Biophys. 1985;241:329-336.
35. Barsigian C, Fellin FM, Jain A, Martinez J. Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-link at the hepatocyte surface. J Biol Chem. 1988;263:14015-14022.
36. Achyuthan KE, Mary A, Greenberg CS. The binding sites on fibrin(ogen) for guinea pig liver transglutaminase are similar to those of blood coagulation factor XIII: characterization of the binding of liver transglutaminase to fibrin. J Biol Chem. 1988;263:14296-14301.
37. Juprelle-Soret M, Wattiaux-DeConnick S, Wattiaux A. Subcellular localization of transglutaminase: effect of collagen. Biochem J. 1988;250:421-427.
38. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 1991;5:3071-3077.
39. Birckbichler PJ, Orr GR, Patterson MK Jr, Conway E, Carter HA. Increase in proliferative marker after inhibition of transglutaminase, Proc Natl Acad Sci U S A. 1981;78:5005-5008.
40. Piacentini M, Autuori F. Immunological localization of tissue transglutaminase and Bcl-2 in rat uterine tissue during embryo implantation and post-atrium involution. Differentiation. 1994;57:51-61.
41. Nara K, Aoyama Y, Iwata T, Hagiwara H, Hirose S. Cell cycle-dependent changes in tissue transglutaminase mRNA levels in bovine endothelial cells. Biochem Biophys Res Commun. 1992;187:14-17.
42. Korner G, Schneider DE, Purdon MA, Bjornsson TD. Bovine aortic endothelial cell transglutaminase. Biochem J. 1989;262:633-641.
43. Kojima S, Nara K, Rifkin DB. Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol. 1993;121:439-448.
44. Cordella-Miele E, Miele L, Mukherjee AB. A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem. 1992; 265:17180-17188.
45. Huang YP, Seguro K, Tawada K. Cross-linking of contractile proteins from skeletal muscle by treatment with microbial transglutaminase. J Biochem. 1992;112:229-234.
46. Leier CV, Binkley PF, Cody RJ. α-Adrenergic component of the sympathetic nervous system in congestive heart failure. Circulation. 1990;82(suppl I):I-168-I-176.
47. 1-adrenergic receptor subtype. Circulation. 1991;83:2076-2082.
48. Downing SE, Lee JC. Contribution of alpha-adrenoceptor activation to the pathogenesis of norepinephrine cardiomyopathy. Circ Res. 1983;52:471-478.
49. 1-adrenergic receptor: characterization of signal transduction pathways and mammalian tissue heterogeneity. Mol Pharmacol. 1991;40:619-626.
50. Birckbichler PJ, Orr GR, Patterson MK Jr. Differential transglutaminase distribution in normal rat liver and rat hepatoma. Cancer Res. 1976;86:2911-2914.
51. van Groningen JJ, Klinik SL, Bloemers HP, Swan GW. Expression of tissue-type transglutaminase correlates positively with metastatic properties of human melanoma cell lines. Int J Cancer. 1995;60:383-387.
52. Kosa K, Meyers K, De Luca LM. Transformation of NIH3T3 cells with ras oncogenes abrogates the retinoic acid induction of tissue transglutaminase. Biochem Biophys Res Commun. 1993;196:1025-1033.
53. Nara K, Nakanish K, Hagiwara H, Wakita K-I, Kojima S, Hirose S. Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. J Biol Chem. 1989;264:19308-19312.
54. Gentile V, Thomazy V, Piacentini M, Fesus L, Davies PJA. Expression of tissue transglutaminase in Balb-C 3T3 fibroblast: effects on cellular morphology and adhesion. J Cell Biol. 1992;119:463-473.